New Key Statistics Module, Z-Score and F-Score
SHSE:600713 Key Ratios
Market Cap ¥ M | 6,873.96 |
Enterprise Value ¥ M | 15,806.83 |
P/E(ttm) | 11.80 |
PE Ratio without NRI | 11.39 |
Forward PE Ratio | -- |
Price/Book | 1.02 |
Price/Sales | 0.12 |
Price/Free Cash Flow | 2.36 |
Price/Owner Earnings | 21.59 |
Payout Ratio % | 0.35 |
Revenue (TTM) ¥ M | 53,981.00 |
EPS (TTM) ¥ | 0.45 |
Beneish M-Score | -2.73 |
10-y EBITDA Growth Rate % | 8.10 |
5-y EBITDA Growth Rate % | 15.90 |
y-y EBITDA Growth Rate % | 2.50 |
EV-to-EBIT | 11.52 |
EV-to-EBITDA | 11.52 |
PEG | 0.72 |
Shares Outstanding M | 1,309.33 |
Net Margin (%) | 1.07 |
Operating Margin % | 2.93 |
Pre-tax Margin (%) | 1.87 |
Quick Ratio | 1.20 |
Current Ratio | 1.50 |
ROA % (ttm) | 1.83 |
ROE % (ttm) | 8.89 |
ROIC % (ttm) | 6.72 |
Dividend Yield % | 3.13 |
Altman Z-Score | 2.44 |
SHSE:600713 Number of Guru Trades
SHSE:600713 Volume of Guru Trades
Gurus Latest Trades with SHSE:600713
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600713 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing Pharmaceutical Co Ltd Insider Transactions
No Available Data